Russell Investments Group Ltd. Raises Stake in Bath & Body Works, Inc. $BBWI

Key Points

• Russell Investments Group Ltd. acquired an additional 18,708 shares of Bath & Body Works, Inc., increasing its holdings by 10.8% to a total of 191,916 shares valued at approximately $5.8 million.
• Bath & Body Works reported $0.49 earnings per share for the last quarter, surpassing analysts' expectations of $0.47, with revenues slightly below estimates at $1.40 billion.
• The company announced a quarterly dividend of $0.20 per share, resulting in a 2.7% yield, and has set its Q2 2025 EPS guidance between 0.330-0.380.

Russell Investments Group Ltd. increased its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 10.8% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 191,916 shares of the company's stock after acquiring an additional 18,708 shares during the quarter. Russell Investments Group Ltd. owned about 0.09% of Bath & Body Works worth $5,819,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in BBWI. Victory Capital Management Inc. grew its holdings in Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock valued at $206,119,000 after buying an additional 6,752,274 shares in the last quarter. D1 Capital Partners L.P. purchased a new position in Bath & Body Works during the 4th quarter valued at about $109,797,000. Assenagon Asset Management S.A. grew its holdings in Bath & Body Works by 3,642.2% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock valued at $50,062,000 after buying an additional 1,606,988 shares in the last quarter. Interval Partners LP purchased a new position in Bath & Body Works during the 4th quarter valued at about $37,992,000. Finally, BNP Paribas Financial Markets purchased a new position in Bath & Body Works during the 4th quarter valued at about $36,445,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Analysts Set New Price Targets

BBWI has been the subject of a number of recent analyst reports. Telsey Advisory Group reaffirmed an "outperform" rating and set a $38.00 target price on shares of Bath & Body Works in a report on Thursday. Citigroup reduced their target price on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a report on Tuesday, August 19th. Morgan Stanley reduced their target price on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Barclays reduced their target price on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a report on Friday, May 30th. Finally, UBS Group boosted their price objective on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a report on Tuesday, May 20th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, Bath & Body Works currently has an average rating of "Moderate Buy" and an average target price of $42.06.

Bath & Body Works Trading Up 5.6%

Shares of NYSE BBWI traded up $1.6350 during midday trading on Friday, hitting $31.0550. 4,792,107 shares of the company's stock were exchanged, compared to its average volume of 4,610,963. Bath & Body Works, Inc. has a 12-month low of $24.94 and a 12-month high of $41.87. The company has a market cap of $6.57 billion, a price-to-earnings ratio of 8.28, a PEG ratio of 1.04 and a beta of 1.54. The business's fifty day moving average price is $30.30 and its two-hundred day moving average price is $30.97.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The company had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same quarter in the previous year, the firm earned $0.38 earnings per share. Bath & Body Works's revenue was up 2.9% on a year-over-year basis. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. Equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 2.6%. Bath & Body Works's dividend payout ratio is currently 21.33%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.